Ph.D., Sr. Epidemiologist and Executive Director, Research, Development, and Dissemination, Sutter Health
Dr. Liberman leads the teams responsible for designing and developing health care solutions and implementing the system-wide DNA and serum biobank. Prior to joining Sutter Health, Dr. Liberman was the Vice President, Research Operations, for the Center for Health Research at Geisinger Health System, where he directed the Center’s operations and developed research collaborations with clinical leaders in Neurosciences, Pediatrics, and Pulmonology. Dr. Liberman was the Vice President of Strategic Research with CVS Health, the largest integrated pharmacy company in the United States and the market leader in mail order; retail clinics; and Medicare Part D prescription drug plans. Dr. Liberman’s research focused on evaluating pharmacy benefit management services, barriers to generic drug and mail-service pharmacy use, and the value of medication adherence. He received his PhD in Epidemiology, School of Hygiene and Public Health; Master of Health Science in Occupational & Environmental Epidemiology; and Bachelor of Arts in Natural Science – Public Health, all from The Johns Hopkins University, Baltimore, Maryland.
Precision Care for MS: Making It Work
Precision Care is a Sutter R&D initiative to ensure patients receive the right care at the right time during ambulatory encounters. We’ve developed a digital platform that integrates applications that integrates in real time with EHRs to obtain PRO, automates visualizing an integrated display of patient data, and supports shared decision making.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: Precision medicine is empowered by access to diverse data, patients, and provider networks. This session will describe the role of health systems as translational research partners that can drive: 1) molecular discoveries; 2) provider and patient engagement through an interoperable platform; and 3) rapid translation of discoveries to clinical practice.